MTOR and rheumatoid arthritis: p-value = 1.9 × 10−3) in SF EVs from RA joints with low-grade inflammation and has been previously described to suppress inflammation by inhibiting: (i) activation of the Akt/mTOR pathway [16], (ii) cytokine expression [17] and (iii) T-cell activation [18].